shortagewatch

Home / Companies / Piramal Critical

Company family

Piramal Critical: medicine shortages

As of 2 Nov 2026, 35 Piramal Critical products have a reported shortage across 7 countries, covering 13 medicines.

Products short35rank #58 of 464
Medicines13active ingredients
Countries7/16
New in 90 days0-8 vs market pace
Typical duration14 monthsmedian so far
Manufacturing46%demand-driven 21%

Where

United States4Italy7Spain1Austria13Belgium1Czechia2Sweden7

Which therapeutic classes

Nervous system28Musculoskeletal system2Blood2Digestive tract and metabolism2Systemic hormones1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Piramal CriticalPiramal Critical: Manufacturing problem 11 (31%)31%Piramal Critical: Increased demand 5 (14%)14%Piramal Critical: Commercial decision or withdrawal 8 (23%)23%Piramal Critical: Not stated 11 (31%)31%All companiesAll companies: Manufacturing problem 4,896 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,220 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes

No changes recorded yet. Changes are tracked from our daily snapshots.

Open shortages over time

2122222331 Oct2026-10-31: 221 Nov2026-11-01: 222 Nov2026-11-02: 22

Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.

When its current shortages began

025710Dec: 0Jan ’25: 1Feb: 0FebMar: 3Apr: 0May: 0MayJun: 1Jul: 0Aug: 2AugSep: 2Oct: 1Nov: 0NovDec: 7Jan ’26: 0Feb: 2FebMar: 1Apr: 0May: 1MayJun: 1Jul: 2Aug: 0AugSep: 0Oct: 0Nov: 0Nov

Against its peers

Viatris995Teva903Sandoz603Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Piramal Critical35

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 603 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 150 / 73Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Piramal Critical: 35 / 13Piramal Critical

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Fentanyl919 Feb 2024Commercial decision or withdrawal7/16
Alfentanil68 Aug 2024Manufacturing problem4/16
Sufentanil61 Mar 2025Manufacturing problem6/16
Miglustat22 Feb 2026Increased demand2/16
Morphine231 Oct 2017Not stated8/16
Piritramide25 Dec 2025Commercial decision or withdrawal1/16
Rocuronium Bromide215 Feb 2023Increased demand5/16
Desflurane125 Aug 2025Manufacturing problem2/16
Etomidate18 Mar 2024Manufacturing problem3/16
Gelatin Agents120 Jul 2026Increased demand2/16
Icatibant111 May 2026Increased demand8/16
Sevoflurane12 Mar 2026Commercial decision or withdrawal2/16
Triamcinolone118 Jun 2025Not stated8/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.